These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37577979)

  • 1. Pyroptosis-related lncRNA prognostic signatures for cutaneous melanoma and tumor microenvironment status.
    Deng H; Chen Y; An R; Wang J
    Epigenomics; 2023 Jun; 15(12):657-675. PubMed ID: 37577979
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
    Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
    Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
    Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction.
    Zhang C; Shen C
    Medicine (Baltimore); 2023 Nov; 102(45):e35881. PubMed ID: 37960805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
    Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
    Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma.
    Li AA; Li F; Lan M; Zhang Y; Xie D; Yan MY
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3227-3241. PubMed ID: 35687183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroptosis-related gene mediated modification patterns and immune cell infiltration landscapes in cutaneous melanoma to aid immunotherapy.
    Meng J; Huang X; Qiu Y; Zheng X; Huang J; Wen Z; Yao J
    Aging (Albany NY); 2021 Nov; 13(21):24379-24401. PubMed ID: 34753832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pyroptosis-related lncRNA signature in bladder cancer.
    Wang P; Wang Z; Zhu L; Sun Y; Castellano L; Stebbing J; Yu Z; Peng L
    Cancer Med; 2023 Mar; 12(5):6348-6364. PubMed ID: 36237132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression pattern of pyroptosis-related genes predicts the prognosis and drug response of melanoma.
    Zhou B; Sha S; Tao J; Li J; Shen C; Zhu J; Tan L; Dong L; Huang C
    Sci Rep; 2022 Dec; 12(1):21566. PubMed ID: 36513682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of pyroptosis-related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer.
    Lv W; Tan Y; Zhao C; Wang Y; Wu M; Wu Y; Ren Y; Zhang Q
    J Cell Mol Med; 2021 Nov; 25(22):10403-10417. PubMed ID: 34632690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature.
    Zhang Z; Shang J; Hu B; Shi H; Cao Y; Li J; Jiao T; Zhang W; Lu S
    Front Immunol; 2022; 13():836576. PubMed ID: 35812396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
    Zhou W; Zhang W
    BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma.
    Chen W; He Y; Zhou G; Chen X; Ye Y; Zhang G; Liu H
    BMC Med; 2024 Jan; 22(1):24. PubMed ID: 38229080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.
    Lin K; Zhou Y; Lin Y; Feng Y; Chen Y; Cai L
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
    Tian J; Yang Y; Li MY; Zhang Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy.
    Wan Q; Deng Y; Wei R; Ma K; Tang J; Deng YP
    Aging (Albany NY); 2024 Mar; 16(5):4518-4540. PubMed ID: 38475660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.